Regulation of c-Jun phosphorylation by the IκB kinase-ε complex in fibroblast-like synoviocytes

Journal of Immunology

Volumn 174, Issue 10, 2005, Pages 6424-6430

  Sweeney, Susan E ^a   Hammaker, Deepa ^a   Boyle, David L ^a   Firestein, Gary S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; CYTOKINE; I KAPPA B KINASE; I KAPPA B KINASE EPSILON; I KAPPA B KINASE RELATED KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; PHOSPHOTRANSFERASE; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE COMPLEX; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; INNATE IMMUNITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE; SYNOVITIS; SYNOVIUM; TRANSCRIPTION REGULATION;

EID: 18644380436     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.10.6424     Document Type: Article

References (43)

1. Firestein, G. S. 2003. Evolving concepts of rheumatoid arthritis. Nature 423: 356-361.
2. Li, Q., and I. Verma. 2002. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2: 725-734.
3. Eferl, R., and E. Wagner. 2003. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3: 859-868.
4. Fujisawa, K., H. Aono, T. Hasunuma, K. Yamamoto, S. Mita, and K. Nishioka. 1996. Activation of transcription factor NF-κB in human synovial cells in response to tumor necrosis factor α. Arthritis Rheum. 39: 197-203.
5. Han, Z., D. L. Boyle, A. M. Manning, and G. S. Firestein. 1998. AP-1 and NF-κB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 28: 197-208.
6. Hammaker, D., S. E. Sweeney, and G. S. Firestein. 2003. Signal transduction networks in rheumatoid arthritis. Ann. Rheum. Dis. 62: 1186-1189.
7. Sweeney, S., and G. Firestein. 2004. Signal transduction in rheumatoid arthritis. Curr. Opin. Rheumatol. 16: 231-237.
8. Roshak, A., J. Callahan, and S. Blake. 2002. Small-molecule inhibitors of NF-κB for the treatment of inflammatory joint disease. Curr. Opin. Pharmacol. 2: 316-321.
9. Aupperle, K., B. Bennett, Z. Han, D. Boyle, A. Manning, and G. Firestein. 2001. NF-κB regulation by IκB kinase-2 in rheumatoid arthritis synoviocytes. J. Immunol. 166: 2705-2711.
10. McIntyre, K. W., D. J. Shuster, K. M. Gillooly, D. M. Dambach, M. A. Pattoli, P. Lu, X. D. Zhou, Y. Qiu, F. C. Zusi, and J. R. Burke. 2003. A highly selective inhibitor of IκB kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice. Arthritis Rheum. 48: 2652-2659.
11. Peters, R., S. Liao, and T. Maniatis. 2000. IKKε is part of a novel PMA-inducible IκB kinase complex. Mol. Cell 5: 513-522.
12. Peters, R., and T. Maniatis. 2001. A new family of IKK-related kinases may function as IκB kinase kinases. Biochim. Biophys. Acta 1471: M57-M62.
13. Shimada, T., T. Kawai, K. Takeda, M. Matsumoto, J. Inoue, Y. Tatsumi, A. Kanamaru, and S. Akira. 1999. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IκB kinases. Int. Immunol. 11: 1357-1362.
14. Kishore, N., C. Sommers, S. Mathialagan, J. Guzova, M. Yao, S. Hauser, K. Huynh, S. Bonar, C. Mielke, L. Albee, et al. 2003. A selective IKK-2 inhibitor blocks NF-κB-dependent gene expression in interleukin-1β-stimulated synovial fibroblasts. J. Biol. Chem. 278: 32861-32871.
15. Nomura, F., T. Kawai, K. Nakanishi, and S. Akira. 2000. NF-κB activation through IKKi dependent I-TRAF/TANK phosphorylation. Genes Cells 5: 191-202.
16. Huynh, Q. K., N. Kishore, S. Mathialagan, A. Donnelly, and C. Tripp. 2002. Kinetic mechanisms of IκB-related kinases (IKK) inducible IKK and TBK-1 differ from IKK-1/IKK-2 heterodimer. J. Biol. Chem. 277: 12550-12558.
17. Fitzgerald, K. A., S. M. McWhirter, K. L. Faia, D. C. Rowe, E. Latz, D. T. Golenbock, A. J. Coyle, S. M. Liao, and T. Maniatis. 2003. IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4: 491-496.
18. Sharma, S., B. R. tenOever, N. Grandvaux, G. P. Zhou, R. Lin, and J. Hiscott. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300: 1148-1151.
19. Alvaro-Gracia, J. M., N. J. Zvaifler, and G. S. Firestein. 1990. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J. Clin. Invest. 86: 1790-1798.
20. Arnett, F. C., S. M. Edworthy, D. A. Bloch, D. J. McShane, J. F. Fries, N. S. Cooper, L. A. Healey, S. R. Kaplan, M. H. Liang, and H. S. Luthra. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315-324.
21. Han, Z., D. Boyle, L. Chang, B. Bennett, M. Karin, L. Yang, A. Manning, and G. Firestein. 2001. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. 108: 73-81.
22. Yamanishi, Y., D. L. Boyle, M. J. Pinkoski, A. Mahboubi, T. Lin, Z. Han, N. J. Zvaifler, D. R. Green, and G. S. Firestein. 2002. Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis. Am. J. Pathol. 160: 123-130.
23. Elices, M. J., V. Tsai, D. Strahl, A. S. Goel, V. Tollefson, T. Arrhenius, E. A. Wayner, F. C. Gaeta, J. D. Fikes, and G. S. Firestein. 1994. Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature. J. Clin. Invest. 93: 405-416.
24. Chabaud-Riou, M., and G. S. Firestein. 2004. Expression and activation of MKK3 and MKK6 in rheumatoid arthritis. Am. J. Pathol. 164: 177-184.
25. Hammaker, D. R., D. L. Boyle, M. Chabaud-Riou, and G. S. Firestein. 2004. Regulation of JNK1 by MEKK2 and MAP kinase kinase kinases in rheumatoid arthritis. J. Immunol. 172: 1612-1618.
26. Boyle, D., S. Rosengren, W. Bugbee, A. Kavanaugh, and G. Firestein. 2003. Quantitative biomarker analysis of synovial gene expression by real-time PCR. Arthritis Res. Ther. 5: R352-R360.
27. Aupperle, K. R., Y. Yamanishi, B. L. Bennett, F. Mercurio, D. L. Boyle, and G. S. Firestein. 2001. Expression and regulation of inducible IκB kinase (IKK-i) in human fibroblast-like synoviocytes. Cell. Immunol. 214: 54-59.
28. Kravchenko, V. V., J. C. Mathison, K. Schwamborn, F. Mercurio, and R. J. Ulevitch. 2003. IKKi/IKKε plays a key role in integrating signals induced by pro-inflammatory stimuli. J. Biol. Chem. 278: 26612-26619.
29. Kim, T., T. Kim, and T. Maniatis. 1998. Efficient recruitment of TFIIB and CBP-RNA polymerase II holoenzyme by an interferon-enhanceosome in vitro. Proc. Natl. Acad. Sci. USA 95: 12191-12196.
30. Malmgaard, L. 2004. Induction and regulation of IFNs during viral infections. J. Interferon Cytokine Res. 24: 439-454.
31. Sundarrajan, M., D. L. Boyle, M. Chabaud-Riou, D. Hammaker, and G. S. Firestein. 2003. Expression of the MAPK kinases MKK-4 and MKK-7 in rheumatoid arthritis and their role as key regulators of JNK. Arthritis Rheum. 48: 2450-2460.
32. Han, Z., L. Chang, Y. Yamanishi, M. Karin, and G. Firestein. 2002. Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis. Arthritis Rheum. 46: 818-823.
33. Moreland, L. W. 2001. Potential biologic agents for treating rheumatoid arthritis. Rheum. Dis. Clin. North Am. 27: 445-491.
34. Firestein, G. 2004. The T cell cometh: interplay between adaptive immunity and cytokine networks in rheumatoid arthritis. J. Clin. Invest. 114: 471-474.
35. Firestein, G., and A. Manning. 1999. Signal transduction and transcription factors in rheumatic disease. Arthritis Rheum. 42: 609-621.
36. Karin, M., Y. Yamamoto, and Q. Wang. 2004. The IKK NF-κB system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3: 17-26.
37. Feldmann, M., E. Andreakos, C. Smith, J. Bondeson, S. Yoshimura, S. Kiriakidis, C. Monaco, C. Gasparini, S. Sacre, A. Lundberg, et al. 2002. Is NF-κB a useful therapeutic target in rheumatoid arthritis? Ann. Rheum. Dis. 61: ii13-ii18.
38. Kyburz, D., J. Rethage, R. Seibl, R. Lauener, R. E. Gay, D. A. Carson, and S. Gay. 2003. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by Toll-like receptor signaling. Arthritis Rheum. 48: 642-650.
39. Choe, J. Y., B. Crain, S. R. Wu, and M. Corr. 2003. Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling. J. Exp. Med. 197: 537-542.
40. Ulevitch, R. 2004. Therapeutics targeting the innate immune system. Nat. Rev. Immunol. 4: 512-520.
41. Coclet-Ninin, J., J. M. Dayer, and D. J. Burger. 1997. Interferon-β not only inhibits interleukin-1β and tumor necrosis factor-α but stimulates interleukin-1 receptor antagonist production in human peripheral blood mononuclear cells. Eur. Cytokine Network 8: 345-349.
42. Triantaphyllopoulos, K., R. Williams, H. Tailor, and Y. Chernajovsky. 1999. Amelioration of collagen-induced arthritis and suppression of interferon-γ, interleukin-12, and tumor necrosis factor α production by interferon-β gene therapy. Arthritis Rheum. 42: 90-99.
43. Ludwig, M., P. Basset, and P. Anglard. 2000. Multiple regulatory elements in the murine stromelysin-3 promoter: evidence for direct control by CCAAT/enhancer-binding protein β and thyroid and retinoid receptors. J. Biol. Chem. 275: 39981-39990.